(Date:12/4/2009)... Therapeutics, Inc. today announced that data from pre-clinical studies of ... in vitro and animal models of human chronic myeloid ... upcoming 51st Annual Meeting of the American Society of Hematology ... 2009. The poster will be presented by Stemline,s collaborators at ...
(Date:12/3/2009)... SAN FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: ... development of compounds for the treatment of cardiovascular and ... last patient visit in its Phase 2 FDG-PET clinical ... 52 patients and was carried out at five sites ...
(Date:12/3/2009)... /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science ... ), spoke at a conference on High-Risk ... 2009. Beike is China,s leading,stem cell research and ... The conference, organized by the Indian Podiatry Association ...
(Date:12/2/2009)... Reportlinker.com announces that a new market research ... Drug Discovery Technologies - A Global ... ,, http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ,, Drug discovery ... of every pharmaceutical company,s business strategy. There ...
Breaking Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9... of Wisconsin's Congressional delegation, Gov. Jim Doyle urged them ... stem cell research and pass the Stem Cell Research Enhancement ... to vote on the measure on Jan. 11. , ,Doyle, who ... bill, also known as HR 3, would lift current barriers on ...
... - With plans to erect as many as five ... is thinking about needs well beyond its existing base ... Dickmann, Epic's chief administrative officer, said the company anticipates adding ... employee count of 2,500. In addition, there remains plenty of ...
... note: As the director of technology programs for the University ... at the forefront of trends in information technology workforce development. ... market need for courses that help IT professionals in their ... two next week. , , Scott Converse also is ...
Other Biology Technology:Epic Systems will build well beyond current staff size 2Phosphatidylinositol transfer protein beta isoform (PtdIns transfer protein beta) (PtdInsTP) (PI-TP-beta). [Source:Uniprot/SWISSPROT;Acc:P48739] Antigen: Recombinant Protein Epitope Signature Tag...
Desmosomal Protein Immunogen: Full length, native protein purified from human epidermal keratins. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse monoclonal [SPM217] to Secretory Component Glycoprotein ( Abpromise for all tested applications)....
Mouse monoclonal [3G8] to MDMA ( Abpromise for all tested applications)....
Biology Products: